跳至主要内容
临床试验/NCT07564102
NCT07564102尚未招募1 期

dMD-002 US Pilot Study A Single-center, Randomized, Double-blind, Pilot Study to Assess the Efficacy and Safety of dMD-002 in Patients After Radical Prostatectomy

Mochida Medical USA, Inc.1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年8月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Mean IIEF-EF scores

研究概览

简要总结

The purpose of this study is to conduct a US Pilot study of dMD-002 as a peripheral nerve repair sheet in patients with cavernous nerve injury following radical prostatectomy. The study will determine which endpoints and timepoints will be used for the pivotal study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 74 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Patients diagnosed with prostate cancer.
  • Patients scheduled to undergo a robot-assisted radical prostatectomy (including either bilateral-nerve sparing or unilateral-nerve sparing) for treatment of prostate cancer.

排除标准

  • Patients undergoing pre-surgery or post-surgery radiation therapy, hormone therapy, or anti-cancer therapy.
  • Patients who have used a penile prosthesis implantation.
  • Patients with a history of transurethral resection, laser therapy, microwave therapy, radiofrequency ablation, cryoablation, or other prostate surgery.

研究组 & 干预措施

Treatment group

Experimental

干预措施: dMD-002 (Device)

Control group

Sham Comparator

干预措施: Control (Other)

结局指标

主要结局

Mean IIEF-EF scores

时间窗: 6 months postoperatively

次要结局

  • Mean EHS score(Screening, 3 weeks, 6 weeks, 3 months, 6 months, 9 months, and 12 months)
  • Mean SHIM score(Screening, 3 weeks, 6 weeks, 3 months, 6 months, 9 months, and 12 months)
  • 24-hour pad weight test(Screening, 6 weeks, and 3 months)
  • Number of Incontinence Episodes/Day(Screening, 6 weeks, and 3 months)

研究者

发起方
Mochida Medical USA, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验